Skip to main content

Imanol Otaegui Irurueta

Institutions of which they are part

Cardiovascular Diseases
Vall Hebron Institut de Recerca

Imanol Otaegui Irurueta

Institutions of which they are part

Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Papel de la activación plaquetaria en el daño microvascular en la fase aguda del infarto y en el remodelado ventircular a medio plazo: posibles determinantes y modulación farmacológica

IP: José Antonio Barrabés Riu
Collaborators: Elsa Nieto Santa, Rosa María Lidón Corbi, Imanol Otaegui Irurueta, Jordi Bañeras Rius
Funding agency: Instituto de Salud Carlos III
Funding: 38115
Reference: PI12/01844
Duration: 01/01/2013 - 31/12/2016

Red Cardiovascular

IP: -
Collaborators: Jorge Guillermo Romero Farina, José Antonio Barrabés Riu, Jose Fernando Rodríguez Palomares, Laura Gutierrez García-Moreno, Antonia Sambola Ayala, Nuria Rivas Gandara, Jordi Perez Rodon, Angeles Rojas Lopez, Antonio Rodríguez Sinovas, Joan Castell Conesa, Artur Evangelista Masip, Josep Pinar Sopena, Teresa González Alujas, Gisela Teixido Tura, Antonia Pijuan Domenech, Enric Domingo Ribas, Gemma Cuberas Borros, Rosa María Lidón Corbi, Francesc Xavier Armengol Castells, Vicente Serra García, Gerard Marti Aguasca, Neus Bellera Gotarda, Imanol Otaegui Irurueta, Ignasi Barba Vert, Jordi Bañeras Rius, Bruno García del Blanco, Pilar Tornos Mas, Elisabet Miro Casas, Marisol Ruiz Meana, Mireia Andres Villarreal, Javier Inserte Igual, Mª Ángeles Carmona Ramírez, Laura Dos Subirá, Maria Nazarena Pizzi
Funding agency: Instituto de Salud Carlos III
Funding: 668059.76
Reference: RD12/0042/0021
Duration: 01/01/2013 - 30/06/2017

Efectividad, coste-efectividad, coste-utilidad y daño neurológico de la implantación de prótesis aótica transcatéter a cirugía convencional en pacientes con estenosis aórtica severa

IP: Ignacio Ferreira González
Collaborators: Jorge Pagola Pérez Blanca, Aida Ribera Sole, José Carlos Sureda Barbosa, Vicente Serra García, Cristina Auger Acosta, Imanol Otaegui Irurueta, Bruno García del Blanco, Pilar Tornos Mas
Funding agency: Instituto de Salud Carlos III
Funding: 209330
Reference: PI10/00369
Duration: 01/01/2011 - 31/12/2014

Características inmunohistoquímicas y moleculares del trombo resistente a la fibrinolisis

IP: Antonia Sambola Ayala
Collaborators: Gerard Marti Aguasca, Neus Bellera Gotarda, Imanol Otaegui Irurueta
Funding agency: Instituto de Salud Carlos III
Funding: 57475
Reference: PI09/01014
Duration: 01/01/2010 - 30/06/2014

Related news

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

Related professionals

M Teresa De la Campa Alonso

M Teresa De la Campa Alonso

Tècnic/a Grau Superior
Prevention of Labor Relations
Human Resources and Lega Area
Read more
Verónica López Blasco

Verónica López Blasco

Predoctoral researcher
Cardiovascular Diseases
Read more
Aitana Diaz Vazquez

Aitana Diaz Vazquez

Research technician
Clinical and Translational Bioinformatics
Read more
Yoursa El-Kasmy El Kasmi

Yoursa El-Kasmy El Kasmi

Administration and Management
General Surgery
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.